https://pharmadog.xyz/news/412575 pharmadog en 2026-09-16T16:29:10.000Z WHO sees declining Ebola transmission in DRC but warns months of work remain https://pharmadog.xyz/news/412363 pharmadog en 2026-09-16T15:37:33.000Z Gilead signs HIV PrEP partnership with PAHO in Latin America https://pharmadog.xyz/news/412319 pharmadog en 2026-09-16T15:10:00.000Z Novo Nordisk partners with Anthropic to boost drug discovery using Claude Science AI https://pharmadog.xyz/news/412172 pharmadog en 2026-09-16T15:00:26.000Z Stanford researchers create mice with human neurons to advance disease studies https://pharmadog.xyz/news/412216 pharmadog en 2026-09-16T15:00:00.000Z Stanford researchers create mice with half human brain tissue using cerebral organoids https://pharmadog.xyz/news/134233 pharmadog en 2026-09-16T14:41:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/412197 pharmadog en 2026-09-16T14:28:29.000Z FDA issues warning letter to Bausch & Lomb over aseptic processing concerns https://pharmadog.xyz/news/412198 pharmadog en 2026-09-16T14:24:26.000Z Psychedelic therapeutics near first FDA approval as Compass Pathways and Definium report promising results https://pharmadog.xyz/news/412173 pharmadog en 2026-09-16T14:10:28.000Z Novo and Anthropic partner to test Claude Science AI platform in drug discovery R&D https://pharmadog.xyz/news/412023 pharmadog en 2026-09-16T13:41:09.000Z Novartis stops ALS TREM2 stabilizer after Phase 2 miss, marking fourth trial setback in a month https://pharmadog.xyz/news/412043 pharmadog en 2026-09-16T13:34:04.000Z Sen. Warren calls for release of Trump-era pharma pricing contracts amid accusations against RFK Jr. https://pharmadog.xyz/news/412044 pharmadog en 2026-09-16T13:29:12.000Z FDA opens applications for pilot program to speed up first-in-human testing https://pharmadog.xyz/news/412469 pharmadog en 2026-09-16T13:05:57.000Z Skyhawk reports functional gains in Huntington's disease trial of RNA-splicing pill https://pharmadog.xyz/news/411895 pharmadog en 2026-09-16T12:30:34.000Z Sling Therapeutics raises $123M Series C to advance oral thyroid eye disease drug https://pharmadog.xyz/news/411767 pharmadog en 2026-09-16T11:56:12.000Z U.S. sees highest number of measles deaths in decades as outbreak spreads to 693 cases https://pharmadog.xyz/news/123087 pharmadog en 2026-09-16T11:49:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/411703 pharmadog en 2026-09-16T11:24:04.000Z Novartis scraps TREM2 ALS candidate after Phase 2 failure https://pharmadog.xyz/news/411595 pharmadog en 2026-09-16T11:00:19.000Z Sling Therapeutics raises $123M to fund Phase 3 trial of former Astellas cancer drug for thyroid eye disease https://pharmadog.xyz/news/411596 pharmadog en 2026-09-16T10:56:58.000Z Skyhawk Therapeutics reports symptom improvement for Huntington's disease in Phase 1/2 extension study https://pharmadog.xyz/news/412122 pharmadog en 2026-09-16T10:28:00.000Z Novartis halts ALS drug VHB937 after phase 2 trial fails to meet endpoints https://pharmadog.xyz/news/411363 pharmadog en 2026-09-16T10:02:08.000Z FDA holds psychedelic forum as Definium reports third successful Phase 3 trial of oral LSD for anxiety https://pharmadog.xyz/news/411954 pharmadog en 2026-09-16T08:32:00.000Z Novartis pays $125 million to acquire Sironax’s brain-delivery platform https://pharmadog.xyz/news/411257 pharmadog en 2026-09-16T08:30:00.000Z Dementia should be a campaign issue, not a political insult, says expert https://pharmadog.xyz/news/411255 pharmadog en 2026-09-16T08:30:00.000Z Democrats pledge to use oversight powers to push health-care reforms if they win Congress https://pharmadog.xyz/news/411256 pharmadog en 2026-09-16T08:30:00.000Z Professor uses his own thymic cancer journey to teach medical students about real-world oncology https://pharmadog.xyz/news/410960 pharmadog en 2026-09-16T07:00:00.000Z Biopharma workers increasingly postpone retirement, poll shows 52% plan to stay longer https://pharmadog.xyz/news/410959 pharmadog en 2026-09-16T07:00:00.000Z Biotech firms race to hire AI-savvy scientists as talent gap widens https://pharmadog.xyz/news/410575 pharmadog en 2026-09-16T05:00:00.000Z Biotech firms increase product launches as capital markets improve https://pharmadog.xyz/news/409315 pharmadog en 2026-09-15T21:13:00.000Z FDA approves first generic radioligand therapy for neuroendocrine tumors as Sionna announces major layoffs https://pharmadog.xyz/news/409837 pharmadog en 2026-09-15T20:31:00.000Z Danone USA recalls So Delicious Dairy Free Salted Caramel Cluster frozen dessert pints over possible foreign material https://pharmadog.xyz/news/408892 pharmadog en 2026-09-15T18:45:31.000Z HHS nominee Chris Klomp faces questioning from Sen. Elizabeth Warren on voluntary drug‑pricing contracts https://pharmadog.xyz/news/408936 pharmadog en 2026-09-15T18:43:59.000Z Fourth measles death reported in Pennsylvania, all victims unvaccinated https://pharmadog.xyz/news/408591 pharmadog en 2026-09-15T16:59:15.000Z FDA approves first radioligand generic, pitting Curium against Novartis' Lutathera https://pharmadog.xyz/news/408592 pharmadog en 2026-09-15T16:28:16.000Z Centric Compounding initiates nationwide recall of three injectable drugs due to API contamination https://pharmadog.xyz/news/411570 pharmadog en 2026-09-15T16:12:00.000Z Sling Therapeutics raises $123M Series C to advance oral thyroid eye disease drug into Phase 3 https://pharmadog.xyz/news/408527 pharmadog en 2026-09-15T16:02:00.000Z New antibody-drug conjugates show promise as potential standard for extensive-stage small cell lung cancer at WCLC 2026 https://pharmadog.xyz/news/408423 pharmadog en 2026-09-15T15:34:08.000Z Sionna Therapeutics to lay off 46% of staff after cystic fibrosis trial setback https://pharmadog.xyz/news/408424 pharmadog en 2026-09-15T15:19:06.000Z Rocket Pharmaceuticals aligns with FDA on Danon therapy as Novo exits Ascendis and Lilly announces new deal https://pharmadog.xyz/news/408320 pharmadog en 2026-09-15T14:55:20.000Z RFK Jr. to keynote Children’s Health Defense event as hospitals criticize GOP rural health fund https://pharmadog.xyz/news/408231 pharmadog en 2026-09-15T14:52:55.000Z FDA launches Operation TrialBlazer to accelerate early-stage drug trials and bring research back to the U.S. https://pharmadog.xyz/news/404463 pharmadog en 2026-09-15T14:33:16.000Z GSK to close German vaccine plant and cut 650 jobs as flu vaccine demand falls https://pharmadog.xyz/news/408321 pharmadog en 2026-09-15T14:28:44.000Z Medicare expands ACCESS pilot to cover more chronic conditions with outcome-based payments https://pharmadog.xyz/news/408208 pharmadog en 2026-09-15T14:24:37.000Z FDA launches expedited IND pilot program, integrating public feedback into qualification criteria https://pharmadog.xyz/news/408209 pharmadog en 2026-09-15T14:16:53.000Z Axoltis reports Phase 2 failure of experimental ALS drug but notes small signal https://pharmadog.xyz/news/408210 pharmadog en 2026-09-15T14:10:40.000Z Omada Health posts first profitable quarter and prepares CEO succession https://pharmadog.xyz/news/408103 pharmadog en 2026-09-15T14:00:00.000Z FDA opens pilot program to speed human testing of new drugs https://pharmadog.xyz/news/408143 pharmadog en 2026-09-15T14:00:00.000Z FDA launches pilot to accelerate early-stage drug trials in the United States https://pharmadog.xyz/news/408083 pharmadog en 2026-09-15T13:58:41.000Z Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meeting https://pharmadog.xyz/news/408084 pharmadog en 2026-09-15T13:56:33.000Z Stakeholders call on FDA to set safety and treatment standards for emerging psychedelic therapies https://pharmadog.xyz/news/408723 pharmadog en 2026-09-15T13:53:31.000Z FDA Opens Expedited IND Pilot to Speed First-in-Human Trials, Applications Accepted Through Oct. 30 https://pharmadog.xyz/news/408104 pharmadog en 2026-09-15T13:50:15.000Z Legend Biotech appoints former Novartis executive as CEO while Vera pursues full approval for kidney drug https://pharmadog.xyz/news/408085 pharmadog en 2026-09-15T13:46:24.000Z Cullinan-Taiho eye FDA filing for zipalertinib after trial shows strong PFS benefit despite three deaths https://pharmadog.xyz/news/408842 pharmadog en 2026-09-15T13:42:00.000Z FDA opens pilot to accelerate phase 1 trials with fast IND reviews https://pharmadog.xyz/news/408086 pharmadog en 2026-09-15T13:33:16.000Z GSK to acquire Chimagen’s trispecific T-cell engager program in deal up to $750 million https://pharmadog.xyz/news/408105 pharmadog en 2026-09-15T13:29:47.000Z STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more https://pharmadog.xyz/news/408087 pharmadog en 2026-09-15T13:13:05.000Z GSK to cut 650 jobs as it shuts German vaccine plant and consolidates production in Canada https://pharmadog.xyz/news/407975 pharmadog en 2026-09-15T13:06:21.000Z New documents expose flaws in Medicare’s rushed AI prior-authorization pilot https://pharmadog.xyz/news/407931 pharmadog en 2026-09-15T13:00:57.000Z Kairon Health raises $5M to turn patient data into actionable to‑do lists for value‑based care practices https://pharmadog.xyz/news/407827 pharmadog en 2026-09-15T12:03:33.000Z NIH now allows businesses to apply for its research funding https://pharmadog.xyz/news/407655 pharmadog en 2026-09-15T11:03:57.000Z GSK signs new agreement with China's Chimagen for trispecific T-cell engager targeting blood cancers https://pharmadog.xyz/news/407656 pharmadog en 2026-09-15T10:30:50.000Z Vera Therapeutics reports two-year data showing Trutakna stabilizes kidney function in IgA nephropathy, paving way for full FDA approval https://pharmadog.xyz/news/407657 pharmadog en 2026-09-15T10:30:19.000Z RegCell secures multi-million dollar Series A to advance Nobel-winning regulatory T-cell therapy https://pharmadog.xyz/news/407699 pharmadog en 2026-09-15T10:30:00.000Z Vera Therapeutics' Trutakna shows kidney function stabilization and lower death risk in Phase 3 IgAN trial https://pharmadog.xyz/news/407658 pharmadog en 2026-09-15T10:29:00.000Z J&J and Contineum's oral M1 inhibitor fails second mid-stage depression trial https://pharmadog.xyz/news/407508 pharmadog en 2026-09-15T10:05:06.000Z Experts urge FDA to require credentials for psychedelic therapy providers https://pharmadog.xyz/news/408183 pharmadog en 2026-09-15T10:00:00.000Z Connect Biopharma's asthma drug rademikibart misses primary endpoint in Phase 2 trial https://pharmadog.xyz/news/407315 pharmadog en 2026-09-15T09:00:00.000Z Exercise and echocardiograms helped keep astronauts’ hearts stable during six-month spaceflight, study finds https://pharmadog.xyz/news/408843 pharmadog en 2026-09-15T08:50:00.000Z Mayo Clinic and Thermo Fisher launch Precure to build large biomedical data set https://pharmadog.xyz/news/408185 pharmadog en 2026-09-15T08:44:00.000Z Eli Lilly partners with QurCan Therapeutics, pledging up to $237 M per CNS genetic-medicine program https://pharmadog.xyz/news/407317 pharmadog en 2026-09-15T08:30:00.000Z States urged to apply tobacco-settlement lessons to Meta’s $18 billion payout https://pharmadog.xyz/news/407316 pharmadog en 2026-09-15T08:30:00.000Z Medicare AI prior-authorization pilot plagued by rollout glitches, causing care delays https://pharmadog.xyz/news/408674 pharmadog en 2026-09-15T08:15:00.000Z Jaguar LAA acquires Johnson & Johnson's Laminar atrial fibrillation device assets https://pharmadog.xyz/news/408187 pharmadog en 2026-09-15T07:21:00.000Z Sionna Therapeutics cuts 46% of staff after cystic fibrosis trial miss https://pharmadog.xyz/news/407739 pharmadog en 2026-09-15T06:21:00.000Z GSK licenses Chimagen trispecific T-cell engager for up to $750 million, targeting phase-1 multiple myeloma study https://pharmadog.xyz/news/407354 pharmadog en 2026-09-15T05:22:00.000Z Novo abandons $285 million partnership with Ascendis for monthly GLP-1 obesity drug https://pharmadog.xyz/news/407738 pharmadog en 2026-09-15T04:27:00.000Z FDA approves Telix's Pixclara, first FET-PET imaging drug for glioma in the U.S. https://pharmadog.xyz/news/406635 pharmadog en 2026-09-15T04:23:00.000Z Blood centers poised to boost cell and gene therapy supply chains https://pharmadog.xyz/news/407246 pharmadog en 2026-09-15T04:08:00.000Z Johnson & Johnson’s depression drug JNJ-5120 fails primary endpoint in phase 2 trial https://pharmadog.xyz/news/408783 pharmadog en 2026-09-15T04:00:00.000Z Medtronic and Given Imaging recall Bravo CF esophageal pH monitoring capsule delivery devices https://pharmadog.xyz/news/410517 pharmadog en 2026-09-15T00:00:00.000Z Experts review five decades of regulatory evolution at RAPS Convergence 2026 https://pharmadog.xyz/news/410075 pharmadog en 2026-09-15T00:00:00.000Z FDA issues warning letters to Bausch & Lomb and Indian API maker over GMP lapses https://pharmadog.xyz/news/410074 pharmadog en 2026-09-15T00:00:00.000Z FDA launches pilot program to speed early-phase drug trials https://pharmadog.xyz/news/410073 pharmadog en 2026-09-15T00:00:00.000Z Experts urge FDA to establish safety and access guidelines for psychedelic drugs; GSK to close German vaccine plant https://pharmadog.xyz/news/405492 pharmadog en 2026-09-14T21:20:48.000Z Judge blocks Trump administration's plan to cap visas for grad students and postdocs https://pharmadog.xyz/news/405355 pharmadog en 2026-09-14T20:41:00.000Z Summit and Akeso report ivonescimab extends lung cancer survival by eight months versus Keytruda in Phase 3 trial https://pharmadog.xyz/news/405187 pharmadog en 2026-09-14T19:18:37.000Z Abbott to pay $385 million to settle claims over 2022 baby-formula plant shutdown https://pharmadog.xyz/news/409582 pharmadog en 2026-09-14T19:06:00.000Z A&P Creations recalls X10 supplement after discovering undeclared Viagra and Cialis ingredients https://pharmadog.xyz/news/404907 pharmadog en 2026-09-14T18:27:25.000Z BioNTech's CTLA-4 antibody gotistobart shows 8.5-month survival boost in previously treated lung cancer patients https://pharmadog.xyz/news/404908 pharmadog en 2026-09-14T18:05:37.000Z FDA seeks external input on rare disease trial criteria and endpoint selection https://pharmadog.xyz/news/404783 pharmadog en 2026-09-14T17:57:47.000Z AAM warns that price pressures threaten sustainability of US generics and biosimilars market